rss
J Neurol Neurosurg Psychiatry 2007;78:551 doi:10.1136/jnnp.2006.108647
  • Carpal tunnel syndrome
  • Editorial commentary

Use of screening blood tests in patients with carpal tunnel syndrome

  1. Jeremy D P Bland
  1. Correspondence to:
 Dr Jeremy D P Bland
 East Kent Hospitals NHS Trust, Neurophysiology, EEG Department, Ethelbert Road, Canterbury CT1 3NG, UK; jbland{at}cix.compulink.co.uk
  • Published Online First 10 November 2006

Is it is worth performing screening investigations in patients with carpal tunnel syndrome without clinical evidence of other diseases?

Carpal tunnel syndrome (CTS) has a fair claim to being the world’s commonest neurological disorder. The way in which it is investigated and treated has substantial economic consequences. One aspect of this is addressed by de Rijk and colleagues1 in this issue of the journal—the utility of screening blood tests in patients with CTS (see p 635). The suggestion that such investigation may not be worthwhile is not new.2 Screening is predicated on the belief that CTS is often secondary to medical disease and CTS …

[Full text of this article]

This Article

  1. Extract
  2. Full text
  3. PDF
  4. All versions of this article:
    1. jnnp.2006.108647v1
    2. 78/6/551 most recent

Responses

  1. Submit a response
  2. No responses published

Register for free content

The full back archive is now available for all BMJ Journals. Institutional subscribers may access the entire archive as part of their subscription. Personal subscribers will also have access to all content when logged in. Non-subscribers who register have free access to all articles published before 2006 right back to volume 1 issue 1. Register here to access the free archive of all BMJ Journals.

Don't forget to sign up for content alerts so you keep up to date with all the articles as they are published.

BMJ Careers - Latest neurology and neurosurgery jobs